13,106.00
0.00
(0.00%)
At close: December 11 at 9:46:11 AM CST
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 13 | 10 | 15 | 16 |
Avg. Estimate | 566.03M | 574.79M | 2.07B | 2.55B |
Low Estimate | 562.36M | 554.63M | 2.07B | 2.5B |
High Estimate | 574.38M | 594.22M | 2.08B | 2.62B |
Year Ago Sales | 432.14M | 460.74M | 1.56B | 2.07B |
Sales Growth (year/est) | 30.98% | 24.75% | 32.69% | 23.13% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
AXON.MX | -- | -- | -- | -- |
S&P 500 | 9.57% | 11.22% | 13.97% | 13.57% |
Upgrades & Downgrades
Initiated | TD Cowen: Buy | 1/8/2025 |
Maintains | Baird: Outperform to Outperform | 12/6/2024 |
Upgrade | Morgan Stanley: Equal-Weight to Overweight | 12/3/2024 |
Maintains | Northland Capital Markets: Outperform to Outperform | 11/11/2024 |
Maintains | Needham: Buy to Buy | 11/8/2024 |
Maintains | Baird: Outperform to Outperform | 11/8/2024 |